Evidence map›Paper›PMID 27207101›Full record

ArticleMalaria journal2016

An evolutionary approach to identify potentially protective B cell epitopes involved in naturally acquired immunity to malaria and the role of EBA-175 in protection amongst denizens of Bolifamba, Cameroon.

Raymond B Nyasa, Helen K Kimbi, Denis Zofou, Jeremy D DeBarry, Jessica C Kissinger, Vincent P K Titanji

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Raymond B NyasaBiotechnology Unit, Faculty of Science, University of Buea, Buea, Cameroon. nyasab@yahoo.co.uk.
Helen K KimbiDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, University of Bamenda, Bamenda, NWR, Cameroon.
Denis ZofouBiotechnology Unit, Faculty of Science, University of Buea, Buea, Cameroon.
Jeremy D DeBarryCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, USA.
Jessica C KissingerCenter for Tropical and Emerging Global Diseases, University of Georgia, Athens, USA.
Vincent P K TitanjiCameroon Christian University, PO Box 5, Bali, NW Region, Cameroon.
University of Buea · CMUniversity of Georgia · USNational Radiation Protection Agency of Cameroon · CMUniversity of Bamenda · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe search for a vaccine against malaria caused by Plasmodium falciparum has lasted for more than 100 years, with considerable progress in the identification of a number of vaccine candidates. The post-genomic era offers new opportunities for an expedited search using rational vaccine design and prioritization of key B-cell epitopes involved in natural acquired immunity.

methodsMalaria vaccine candidate genes that have reached clinical trial were searched on an evolutionary relationship tree, to determine their level of lineage-specificity. Ten other genes with similar protein features and level of lineage specificity to the vaccine candidates were randomly selected, and computationally evaluated for the presence of B-cell epitopes. The protein fragment with maximum probability of putative epitopes were synthesized and used in an ELISA experiment to determine the presence of antibodies to these peptides, in the serum of malaria patients and healthy malaria uninfected inhabitants from a malaria endemic region (Bolifamba), alongside with a vaccine candidate EBA-175.

resultsTwo peptide fragments of 25 and 30 amino acid length from PF3D7_1233400 and PF3D7_1437500 respectively, coded as PF4-123 and PF4-143 were shown to contain B-cell epitope(s). Total IgG antibodies to these peptides were not significantly different between sick and healthy participants, but cytophilic antibodies to these peptides were significantly higher in healthy participants (p < 0.03). Total IgG to the vaccine candidate EBA-175 was significantly higher in sick participants than in healthy participants, likewise cytophilic antibodies (p < 0.04). Antibodies to the peptides PF4-123 and PF4-143 correlated negatively (p = 0.025 and 0.008 and r = -0.291 and -0.345, respectively) to parasite load. Total IgG antibodies to EBA-175 showed a negative correlation to parasite load (r = -0.144), which was not significant (p = 0.276). Duration of stay in Bolifamba also negatively correlated with parasite load (p = 0.026, r = -0.419) and total IgG to PF4-143 was significantly associated with prolonged duration of stay in the locality of Bolifamba, Cameroon (p = 0.006, r = 0.361).

conclusionsThe present study has identified two genes PF3D7_1233400 and PF3D7_1437500 containing peptide fragment (PF4-123 and PF4-143) with B-cell epitopes that are correlated with naturally acquired immunity to malaria. A pipeline has been developed for rapid identification of other B-cell epitopes involved in naturally acquired immunity.

Indexed as

Adaptive ImmunityAdolescentAdultAntibodies, ProtozoanAntigens, ProtozoanCameroonChild, PreschoolEpitopes, B-LymphocyteFemaleHumansInfantMalariaMalePlasmodium falciparumProtozoan ProteinsYoung AdultAntibodies, ProtozoanAntigens, ProtozoanEpitopes, B-Lymphocyteerythrocyte-binding antigen 175, PlasmodiumProtozoan ProteinsCameroonDuration of stayEBA-175Hypothetical genesLineage-specificMalariaNatural acquired immunity

Identifiers

PMID27207101
PMCPMC4875671
OpenAlexW2399810406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.